Publication Name	World Journal of Gastroenterology
Manuscript ID	26218
Country	United States

Received	2016-03-31 09:36
Peer-Review Started	2016-04-06 08:28
To Make the First Decision	2016-05-30 09:21
Return for Revision	2016-05-30 14:14
Revised	2016-06-13 13:48
Second Decision	2016-06-23 17:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-07-06 18:50
Articles in Press	2016-07-06 18:50
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-08-06 17:56
Publish the Manuscript Online	2016-08-15 10:30

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma
Manuscript Source	Invited Manuscript
All Author List	Chung-Tzu Hsueh, Julie H Selim, James Y Tsai and Chung-Tsen Hsueh
Funding Agency and Grant Number
Corresponding Author	Chung-Tsen Hsueh, MD, PhD, Division of Medical Oncology and Hematology, Department of Internal Medicine, Loma Linda University, 11175 Campus Street, CSP 11015, Loma Linda, CA 92354, United States. chsueh@llu.edu
Key Words	Pancreatic adenocarcinoma; Nanovector; Nanoparticle albumin-bound paclitaxel; Nanoliposomal irinotecan; Biomarker
Core Tip	The nanovector-based anti-cancer therapeu-tics play important role in the treatment of advanced pancreatic adenocarcinoma. Data from completed clinical trials are reviewed, and important ongoing studies are presented. Biomarkers for patient selection and personalized medicine are discussed.
Publish Date	2016-08-15 10:30
Citation	Hsueh CT, Selim JH, Tsai JY, Hsueh CT. Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma. World J Gastroenterol 2016; 22(31): 7080-7090
URL	http://www.wjgnet.com/1007-9327/full/v22/i31/7080.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i31.7080

Full Article (PDF)	WJG-22-7080.pdf
Full Article (Word)	WJG-22-7080.doc
Manuscript File	26218-Review.doc
Answering Reviewers	26218-Answering reviewers.pdf
Audio Core Tip	26218-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	26218-Conflict-of-interest statement.pdf
Copyright License Agreement	26218-Copyright assignment.pdf
Peer-review Report	26218-Peer-review(s).pdf
Scientific Misconduct Check	26218-Scientific misconduct check.pdf
Scientific Editor Work List	26218-Scientific editor work list.pdf